About
Transcranial Electromagnetic Treatment
Areas of Focus
Categories
Uncategorized Medical DeviceSoutheastern U.S.
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
121
By Phase
NA: 3PHASE1/PHASE2: 1
By Status
COMPLETED: 2ENROLLING_BY_INVITATION: 1UNKNOWN: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT07049341Lead Sponsor
Pilot Trial Evaluating Patient Experience With the MemorEM for Patients With Neurological Diseases
NAEnrolling by invitation
100 participants
Started: Jul 31, 2025 · Completed: Jun 30, 2028
NCT04271163Lead Sponsor
Transcranial Electromagnetic Treatment (TEMT) Against Alzheimer's Disease
PHASE1/PHASE2Unknown
6 participants
Started: Feb 10, 2020 · Completed: Mar 31, 2021
NCT03927040Lead Sponsor
Transcranial Electromagnetic Treatment Against Alzheimer's Disease
NACompleted
7 participants
Started: Apr 15, 2019 · Completed: Oct 30, 2020
NCT02958930Lead Sponsor
Safety and Efficacy of Transcranial Electromagnetic Treatment Against Alzheimer's Disease
NACompleted
8 participants
Started: Oct 1, 2017 · Completed: Jan 11, 2019
Locations (1)
Headquarters
Tampa, FL, United States
Map
Loading map...